<DOC>
	<DOCNO>NCT01375660</DOCNO>
	<brief_summary>This study supplement African American male ( AAM ) veteran risk diabetes newly diagnose T2DM vitamin D ( low high dose ) evaluate whether vitamin D help improve early marker diabetes . The study do Veteran Administration Medical Center Chicago .</brief_summary>
	<brief_title>D Vitamin Intervention VA</brief_title>
	<detailed_description>The goal randomize clinical trial ( RCT ) determine vitamin D efficacy safety improve early marker T2DM African American male ( AAM ) veteran risk T2DM ( n=205 , duration 12 month ) . The primary outcome change oral glucose insulin sensitivity ( OGIS ) . The secondary outcome include various parameter glucose metabolism biomarkers . Analysis base primary secondary goal well predetermined level A1C , OGTT 25OHD end study .</detailed_description>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<criteria>Veterans Jesse Brown VA Medical Center ( JBVAMC ) Male African American race Age 3585 year BMI 2839.9 kg/m2 Stable weight ( +/ 10 % ) least 3 month prior study entry FPG 95 125 mg/dl A1C 5.7 6.4 % Circulating 25OHD 5.0 29.9 ng/ml Subjects take ergocalciferol allow study washout period 1 3 month . Subjects take vitamin D supplement ergocalciferol allow study long total dose 600 IU/day ( include MVI calcium plus D supplement ) . Nondiabetic subject diagnose T2DM screening ( A1C 6.57 % ) randomization allow continue follow lifestyle intervention need take antidiabetic medication . Subjects T2DM Weight gain loss 10 % within 3 month prior study entry History kidney stone , hyperparathyroidism , sarcoidosis hypercalcemia A1C &gt; 7 % . Very low 25OHD level ( &lt; 5 ng/ml ) and/or presence physical consequence low vitamin D level ( hypocalcemia , hypophosphatemia , proximal muscle weakness ) Chronic kidney disease ( CKD ) stage 4 5 Problems judgment PI may associate risk subject noncompliance Subjects take vitamin D supplement willing go washout period ergocalciferol take 600 IU/day total vitamin D supplement History , clinical manifestation medication significant metabolic , hepatic , renal , hematological , pulmonary , cardiovascular , gastrointestinal , urological , neurological , psychiatric/ psychological disorder , social circumstance opinion investigator would expect interfere study increase risk subject Nondiabetic subject diagnose T2DM randomization need take antidiabetic medication bring final visit</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Glucose intolerance</keyword>
	<keyword>African American men</keyword>
</DOC>